These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 25152587)
21. Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts. Papatheodoridi M; Cholongitas E Curr Pharm Des; 2018; 24(38):4574-4586. PubMed ID: 30652642 [TBL] [Abstract][Full Text] [Related]
22. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis. Golabi P; Sayiner M; Fazel Y; Koenig A; Henry L; Younossi ZM Expert Rev Gastroenterol Hepatol; 2016; 10(1):63-71. PubMed ID: 26469309 [TBL] [Abstract][Full Text] [Related]
23. Imaging biomarkers of NAFLD, NASH, and fibrosis. Ajmera V; Loomba R Mol Metab; 2021 Aug; 50():101167. PubMed ID: 33460786 [TBL] [Abstract][Full Text] [Related]
24. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease. Alkhouri N; Sedki E; Alisi A; Lopez R; Pinzani M; Feldstein AE; Nobili V Liver Int; 2013 Jan; 33(1):79-85. PubMed ID: 23146095 [TBL] [Abstract][Full Text] [Related]
25. Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease. Hu KC; Wang HY; Liu SC; Liu CC; Hung CL; Bair MJ; Liu CJ; Wu MS; Shih SC World J Gastroenterol; 2014 Jun; 20(24):7718-29. PubMed ID: 24976709 [TBL] [Abstract][Full Text] [Related]
26. Distribution of liver stiffness in non-alcoholic fatty liver disease with higher fibrosis-4 index than low cut-off index. Tomeno W; Imajo K; Kuwada Y; Ogawa Y; Kikuchi M; Honda Y; Kato T; Kessoku T; Kirikoshi H; Yoneda M; Kitahora T; Saito S; Ozawa Y; Nakajima A J Gastroenterol Hepatol; 2019 Aug; 34(8):1411-1416. PubMed ID: 30506860 [TBL] [Abstract][Full Text] [Related]
27. Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver disease. Caussy C; Ajmera VH; Puri P; Hsu CL; Bassirian S; Mgdsyan M; Singh S; Faulkner C; Valasek MA; Rizo E; Richards L; Brenner DA; Sirlin CB; Sanyal AJ; Loomba R Gut; 2019 Oct; 68(10):1884-1892. PubMed ID: 30567742 [TBL] [Abstract][Full Text] [Related]
28. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. Zhou JH; Cai JJ; She ZG; Li HL World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425 [TBL] [Abstract][Full Text] [Related]
29. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease. Staufer K; Halilbasic E; Spindelboeck W; Eilenberg M; Prager G; Stadlbauer V; Posch A; Munda P; Marculescu R; Obermayer-Pietsch B; Stift J; Lackner C; Trauner M; Stauber RE United European Gastroenterol J; 2019 Oct; 7(8):1113-1123. PubMed ID: 31662868 [TBL] [Abstract][Full Text] [Related]
30. Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness. Liebig S; Stoeckmann N; Geier A; Rau M; Schattenberg JM; Bahr MJ; Manns MP; Jaeckel E; Schulze-Osthoff K; Bantel H Clin Transl Gastroenterol; 2019 Aug; 10(8):e00066. PubMed ID: 31397685 [TBL] [Abstract][Full Text] [Related]
32. Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease. Bedossa P; Patel K Gastroenterology; 2016 Jun; 150(8):1811-1822.e4. PubMed ID: 27003601 [TBL] [Abstract][Full Text] [Related]
33. The search for noninvasive methods to identify liver fibrosis in children with nonalcoholic fatty liver disease. Mandelia C; Kabbany MN; Conjeevaram Selvakumar PK; Alkhouri N Biomark Med; 2018 Mar; 12(3):265-273. PubMed ID: 29517271 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic accuracy of combined biomarker measurements and vibration-controlled transient elastography (VCTE) for predicting fibrosis stage of non-alcoholic fatty liver disease. Shima T; Sakai K; Oya H; Katayama T; Mitsumoto Y; Mizuno M; Kanbara Y; Okanoue T J Gastroenterol; 2020 Jan; 55(1):100-112. PubMed ID: 31538241 [TBL] [Abstract][Full Text] [Related]
35. American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. Singh S; Muir AJ; Dieterich DT; Falck-Ytter YT Gastroenterology; 2017 May; 152(6):1544-1577. PubMed ID: 28442120 [TBL] [Abstract][Full Text] [Related]
36. Current status of fibrosis markers. Patel K; Shackel NA Curr Opin Gastroenterol; 2014 May; 30(3):253-9. PubMed ID: 24671009 [TBL] [Abstract][Full Text] [Related]
37. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease. Mansoor S; Yerian L; Kohli R; Xanthakos S; Angulo P; Ling S; Lopez R; Christine CK; Feldstein AE; Alkhouri N Dig Dis Sci; 2015 May; 60(5):1440-7. PubMed ID: 25540086 [TBL] [Abstract][Full Text] [Related]
38. Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future. Adams LA; Chan WK Semin Liver Dis; 2020 Nov; 40(4):331-338. PubMed ID: 32526784 [TBL] [Abstract][Full Text] [Related]
39. A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic Fatty liver disease. Mansoor S; Collyer E; Alkhouri N Curr Gastroenterol Rep; 2015 Jun; 17(6):23. PubMed ID: 26031832 [TBL] [Abstract][Full Text] [Related]